Skip to main content

Market Overview

56 Biggest Movers From Yesterday



  • American Electric Technologies, Inc (NASDAQ: AETI) shares climbed 169.93 percent to close at $1.08 on Monday after the company disclosed that its joint venture, BOMAY, received a major order for drilling rig control systems.
  • TESARO Inc (NASDAQ: TSRO) gained 58.47 percent to close at $73.50 after GlaxoSmithKline plc (NYSE: GSK) announced plans to acquire the company for $75 per share in cash.
  • Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares climbed 47.81 percent to close at $46.62. Global Blood announced Monday that the FDA has agreed to allow filing for its late-stage sickle cell disease, or SCD, candidate Voxelotor under an accelerated approval pathway. The company said it would submit a new drug application, or NDA, for the pipeline asset under the pathway.
  • Guardant Health, Inc. (NASDAQ: GH) gained 28.58 percent to close at $45.94.
  • Lilis Energy, Inc. (NYSE: LLEX) rose 27.67 percent to close at $2.63.
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares rose 25.68 percent to close at $31.47 after the company's phase 2 study of Tradipitant met its primary endpoint and most secondary endpoints.
  • Biohaven Pharmaceutical Holding Company Ltd. (NASDAQ: BHVN) rose 25.39 percent to close at $42.62 after reporting positive Phase 3 results with rimegepant zydis orally dissolving tablet for the acute treatment of migraine.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) gained 17.73 percent to close at $18.06 after presents updated data from ongoing APL-2 Phase 2 clinical study at the ASH 2018.
  • Laredo Petroleum, Inc. (NYSE: LPI) climbed 17.39 percent to close at $5.13.
  • Provention Bio, Inc. (NASDAQ: PRVB) gained 16.88 percent to close at $2.70.
  • Elastic N.V. (NYSE: ESTC) climbed 14.77 percent to close at $82.00.
  • Aeterna Zentaris Inc. (NASDAQ: AEZS) gained 14.5 percent to close at $3.87.
  • SI-BONE, Inc. (NASDAQ: SIBN) surged 13.81 percent to close at $20.44.
  • argenx SE (NASDAQ: ARGX) rose 13.49 percent to close at $109.82 after Janssen affiliate Cilag GmbH International disclosed a worldwide collaboration and license agreement with Argenx for cancer immunotherapy cusatuzumab.
  • Cenovus Energy Inc. (NYSE: CVE) shares jumped 12.87 percent to close at $8.33.
  • SG Blocks, Inc. (NASDAQ: SGBX) jumped 12.54 percent to close at $3.68 after receiving a $25 million purchase order from Phoenix Hotel & Hospitality.
  • Vapotherm, Inc. (NYSE: VAPO) gained 12.29 percent to close at $20.65.
  • Arcus Biosciences, Inc. (NYSE: RCUS) rose 12.17 percent to close at $12.81.
  • Osmotica Pharmaceuticals plc (NASDAQ: OSMT) climbed 12.06 percent to close at $8.83.
  • Seadrill Limited (NYSE: SDRL) shares rose 11.96 percent to close at $15.26 after dropping 7.40 percent on Friday.
  • Tribune Media Company (NYSE: TRCO) rose 11.72 percent to close at $44.98 after Nexstar Media Group Inc (NASDAQ: NXST) announced plans to acquire the company for $46.50 per share.
  • Crescent Point Energy Corp. (NYSE: CPG) gained 11.49 percent to close at $3.30.
  • Forterra, Inc. (NASDAQ: FRTA) jumped 11.43 percent to close at $5.46.
  • Advanced Micro Devices, Inc. (NASDAQ: AMD) gained 11.31 percent to close at $23.71.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) rose 10.87 percent to close at $19.08.
  • ZAGG Inc (NASDAQ: ZAGG) gained 9.95 percent to close at $11.05.
  • Wynn Resorts, Limited (NASDAQ: WYNN) rose 9.5 percent to close at $119.79.
  • New Age Beverages Corporation (NASDAQ: NBEV) rose 9.07 percent to close at $5.05 after the company announced plans to acquire Morinda Holdings, Inc. for $75 million in cash and $10 million in stock.
  • RadiSys Corporation (NASDAQ: RSYS) rose 6.83 percent to close at $1.72 after the company reported the CFIUS clearance related to its acquisition of Reliance Industries.
  • Chart Industries, Inc. (NASDAQ: GTLS) rose 6.75 percent to close at $67.85. Evercore ISI Group upgraded Chart Industries from In-Line to Outperform.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) gained 5.31 percent to close at $4.56 after reporting China market approval of Melphalan Hydrochloride for injection.



  • Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) shares dipped 37.59 percent to close at $6.31 on Monday after reporting top-line results from a Phase 2b study of SNA-120.
  • Hexindai Inc. (NASDAQ: HX) shares dropped 27.73 percent to close at $3.18 following Q2 results. Hexindai posted a Q2 loss of $0.36 per share on sales of $3.62 million.
  • Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) fell 26.3 percent to close at $2.83 on Monday after rising 37.14 percent on Friday.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) dropped 23.77 percent to close at $4.345 on Monday.
  • Aphria Inc. (NYSE: APHA) declined 23.42 percent to close at $6.05 after Reuters reported that 2 research firms issued negative reports on the stock.
  • Arlo Technologies, Inc. (NYSE: ARLO) shares declined 22.86 percent to close at $9.28. Arlo Technologies expects Q4 sales of $125 million to $130 million.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares fell 22.16 percent to close at $4.04 after dropping 25.54 percent on Friday.
  • Tel-Instrument Electronics Corp. (NYSE: TIK) fell 20.16 percent to close at $3.09 after surging 57.96 percent on Friday.
  • Realm Therapeutics Plc (NASDAQ: RLM) shares tumbled 17.79 percent to close at $2.45.
  • Sphere 3D Corp. (NASDAQ: ANY) dropped 17.49 percent to close at $4.34.
  • Kodiak Sciences Inc. (NASDAQ: KOD) dipped 14.05 percent to close at $7.95.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 13.96 percent to close at $5.73. Cantor Fitzgerald reiterated Overweight rating on Ocular Therapeutics following the FDA approval of DEXTENZA.
  • Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) fell 13.66 percent to close at $56.81 after presenting updated data from the ivosidenib Phase 1 dose-escalation and expansion trial in IDH1 mutant positive patients with newly diagnosed acute myeloid leukemia ineligible for standard treatment and myelodysplastic syndrome.
  • StoneMor Partners L.P. (NYSE: STON) dropped 13.14 percent to close at $3.04.
  • Arsanis, Inc. (NASDAQ: ASNS) tumbled 13.11 percent to close at $3.38.
  • Alliqua BioMedical, Inc. (NASDAQ: ALQA) shares dipped 13.04 percent to close at $2.40.
  • UTStarcom Holdings Corp. (NASDAQ: UTSI) shares declined 12.61 percent to close at $3.12.
  • Trillium Therapeutics Inc. (NASDAQ: TRIL) fell 12.29 percent to close at $2.64 following an update on its intratumoral TTI-621 program at the American Society of Hematology 60th Annual Meeting.
  • Xcel Brands, Inc. (NASDAQ: XELB) fell 10.63 percent to close at $1.85.
  • Gamida Cell Ltd. (NASDAQ: GMDA) dropped 10.38 percent to close at $13.81.
  • Aptinyx Inc. (NASDAQ: APTX) fell 10 percent to close at $19.99. Aptinyx achieved its primary endpoint in the study of NYX-2925.
  • Arvinas Holding Company, LLC (NASDAQ: ARVN) dropped 9.58 percent to close at $15.29.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) dipped 7.58 percent to close at $3.05.
  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) dropped 6.13 percent to close at $9.18.
  • bluebird bio, Inc. (NASDAQ: BLUE) fell 5.2 percent to close at $116.50. bluebird bio and Celgene Corporation (NASDAQ: CELG) presented initial Phase 1 data for multiple myeloma treatment candidate bb21217 at ASH 2018.

Related Articles (AETI + ADIL)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at